Phathom Pharmaceuticals announces DDW2026 booth and team participation in Chicago

Phathom Pharmaceuticals announces DDW2026 booth and team participation in Chicago
Phathom joins DDW2026 in Chicago

Phathom Pharmaceuticals announced its upcoming participation at Digestive Disease Week (DDW2026) in Chicago.

The company invited attendees to visit booth 2511 to meet its team and referenced an official press release with more details about its planned presence at the event. Phathom Pharmaceuticals continues to focus on engagement with the gastroenterology community at major industry conferences.

Phathom previously announced plans for a live DDW2026 session to present new clinical efficacy and safety data on VOQUEZNA, its gastrointestinal treatment, at the same event in Chicago (article). The company has also participated in industry forums focused on patient engagement, including a ThinkDHC webinar featuring SVP Nancy Phelan's insights on point-of-care marketing (article). These appearances mark ongoing efforts by Phathom to maintain visibility within the gastroenterology sector.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.